Arovella Therapeutics appoints CAR-iNKT cell pioneer to Scientific Advisory Board proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
Arovella Therapeutics Ltd (ASX:ALA) has obtained an exclusive option to license a cytokine technology which could enhance iNKT cells, allowing them to.